Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M Pro inhibitors with potent in vivo efficacy
2025; American Association for the Advancement of Science; Volume: 11; Issue: 17 Linguagem: Inglês
10.1126/sciadv.adt7836
ISSN2375-2548
AutoresTyler C. Detomasi, Gilles Degotte, Sijie Huang, Rahul K. Suryawanshi, Amy Diallo, Luca Lizzadro, Francisco J. Zaptero-Belinchón, Taha Y. Taha, Jiapeng Li, Alicia Richards, Eric R. Hantz, Zain Alam, Mauricio Montaño, Maria McCavitt-Malvido, R. Gumpena, James R. Partridge, G.J. Correy, Yusuke Matsui, Annemarie F. Charvat, Isabella Glenn, Julia Rosecrans, Jezrael L. Revalde, David J. Anderson, Judd F. Hultquist, Michelle R. Arkin, R. Jeffrey Neitz, Danielle L. Swaney, Nevan J. Krogan, Brian K. Shoichet, Kliment A. Verba, Mélanie Ott, Adam R. Renslo, Charles S. Craik,
Tópico(s)Animal Virus Infections Studies
Referência(s)